Lista de obras -

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

artículo científico publicado en 2015

BRCA1 testing in breast and/or ovarian cancer families from northeastern France identifies two common mutations with a founder effect

artículo científico publicado en 2004

BRCA1 wild-type allele modifies risk of ovarian cancer in carriers of BRCA1 germ-line mutations

artículo científico publicado en 2003

Breast Cancer Risk Associated with Estrogen Exposure and Truncating Mutation Location in BRCA1/2 Carriers

artículo científico publicado en 2015

Breast cancer risk inBRCA1 andBRCA2 mutation carriers and polyglutamine repeat length in theAIB1 gene

article

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.

artículo científico publicado en 2011

Efficacy of anthracycline/taxane-based neo-adjuvant chemotherapy on triple-negative breast cancer in BRCA1/BRCA2 mutation carriers

artículo científico publicado en 2017

Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers

artículo científico publicado en 2010

Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK).

artículo científico publicado en 2012

Familial breast cancer and DNA repair genes: insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing

article

GENESIS: a French national resource to study the missing heritability of breast cancer

artículo científico publicado en 2016

Impact of an information booklet on satisfaction and decision-making about BRCA genetic testing

artículo científico publicado en 2006

Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers.

artículo científico publicado en 2018

Mutation analysis of PALB2 gene in French breast cancer families

article

Mutation screening of MIR146A/B and BRCA1/2 3'-UTRs in the GENESIS study

artículo científico publicado en 2016

No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study

artículo científico publicado en 2008

Patients' characteristics and rate of Internet use to obtain cancer information

artículo científico publicado en 2006

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

artículo científico publicado en 2017

Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families

scientific article published on 01 October 2002

Telomere length, ATM mutation status and cancer risk in Ataxia-Telangiectasia families

artículo científico publicado en 2017

The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma

artículo científico publicado en 2008

Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial

artículo científico

Uptake of genetic counseling among adult children of BRCA1/2 mutation carriers in France

scientific article published on 17 July 2019

Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO).

artículo científico publicado en 2012

Variation in breast cancer risk with mutation position, smoking, alcohol, and chest X-ray history, in the French National BRCA1/2 carrier cohort (GENEPSO)

artículo científico publicado en 2011

Which factors predict proposal and uptake of psychological counselling after BRCA1/2 test result disclosure?

artículo científico publicado en 2013

Lista de obras de

Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer

BRCA1 testing in breast and/or ovarian cancer families from northeastern France identifies two common mutations with a founder effect

BRCA1 wild-type allele modifies risk of ovarian cancer in carriers of BRCA1 germ-line mutations

Breast Cancer Risk Associated with Estrogen Exposure and Truncating Mutation Location in BRCA1/2 Carriers

Breast cancer risk inBRCA1 andBRCA2 mutation carriers and polyglutamine repeat length in theAIB1 gene

Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2.

Efficacy of anthracycline/taxane-based neo-adjuvant chemotherapy on triple-negative breast cancer in BRCA1/BRCA2 mutation carriers

Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers

Exposure to diagnostic radiation and risk of breast cancer among carriers of BRCA1/2 mutations: retrospective cohort study (GENE-RAD-RISK).

Familial breast cancer and DNA repair genes: insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing

GENESIS: a French national resource to study the missing heritability of breast cancer

Impact of an information booklet on satisfaction and decision-making about BRCA genetic testing

Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers.

Mutation analysis of PALB2 gene in French breast cancer families

Mutation screening of MIR146A/B and BRCA1/2 3'-UTRs in the GENESIS study

No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study

Patients' characteristics and rate of Internet use to obtain cancer information

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

Significant contribution of large BRCA1 gene rearrangements in 120 French breast and ovarian cancer families

Telomere length, ATM mutation status and cancer risk in Ataxia-Telangiectasia families

The contribution of large genomic deletions at the CDKN2A locus to the burden of familial melanoma

Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial

Uptake of genetic counseling among adult children of BRCA1/2 mutation carriers in France

Variation in breast cancer risk associated with factors related to pregnancies according to truncating mutation location, in the French National BRCA1 and BRCA2 mutations carrier cohort (GENEPSO).

Variation in breast cancer risk with mutation position, smoking, alcohol, and chest X-ray history, in the French National BRCA1/2 carrier cohort (GENEPSO)

Which factors predict proposal and uptake of psychological counselling after BRCA1/2 test result disclosure?